We welcome researchers from all around the globe to be a part of 3rd International Conference on HIV/AIDS, STD & STI scheduled in Singapore city, Singapore on April 22-23, 2020. The 2020 edition of the summit will move forward with the theme “Aiming for an HIV Free Society”.
Scientific Sessions: Evolution of HIV, HIV & Chronic Disease, HIV and Pregnancy, Living with HIV, AIDS Research and Therapy, STD, STIs and Infertility, Gender Inequality and HIV, Progress for HIV Vaccine, HIV: Treatment for all, Preventing STD & STI.
Singapore city will serve as the venue for HIV 2020 conference and will provide participants a view of diverse language, religion &culture. The destinations which make Singapore special are Marina Bay Sands, Gardens by the Bay, Orchard Road, Chinatown, Sentosa Island, Clarke Quay, Universal Studios Singapore, Night Safari Singapore, Merlion Park etc.
Session 1: Evolution of HIV
Human Immunodeficiency Virus (HIV) originated in Central and West Africa in non-human primates and of two types: HIV-1 and HIV-2. HIV-1causes majority of HIV infections globally being more virulent and easily transmitted while HIV-2 which is less transmittable. According to researchers, HIV evolved from the closely related SIV which after post mutation transformed to humans from non-human primates as HIV in form of zoonosis. To determine relatedness, molecular phylogenetic process used comparing viral genomic sequences.
Session 2: HIV & Chronic Disease
AIDS is like that of a chronic disease as both of them generally can’t be prevented by vaccines or cured by medication persisting for a long time even they don’t disappear but however, some antiviral drugs can effect against the virus preventing transmission in case HIV but, there is an increase in HIV level and decrease in number of CD4 cells during chronic HIV infection.
Session 3: HIV and Pregnancy
In the uterus, a baby can be infected with HIV. By taking treatments, the percentage of HIV infected babies born to women can be reduced to less and the treatment is received as a low viral load during pregnancy which can reduce the chances of passing HIV from mother to child during pregnancy and childbirth. The symptoms of HIV during pregnancy can be rapid weight loss, dry cough, night sweating, swollen lymph glands in the armpits or necks, unusual blemishes on the tongue, in throat or mouth, red or brown blotches on the skin, nose, mouth or eyelids.
Session 4: Living with HIV
As HIV often presents no physical symptoms, it is impossible by looking at someone to know if he or she is infected by HIV. From major reports of HIV positive people, the survival rate has improved. Now they can expect to live as long as someone who doesn’t have HIV by taking antiviral treatment, exercising regularly, eating healthily, managing stress & getting support and avoiding excessive alcohol drug use. Because, once HIV multiplies inside the host cells, his or her immune system will no longer be able to protect the body.
Session 5: AIDS Research and Therapy
Research on HIV generally aims at preventation, treatment as well as care of AIDS and other HIV related diseases. Research part includes decreasing the side effect of the medicines, further simplification of the drug structure as well as what treatment doctor should recommend for the HIV infected people. Therapy is generally for developing a healthy immune system to decrease the complication.
Session 6: STD, STIs and Infertility
Chlamydia and gonorrhea are major cause of pelvic inflammatory disease (PID) as well as infertility. Chlamydia can also lead to fallopian tube infection. PID can also cause pregnant damage to the fallopian tubes, uterus and surrounding tissues, which can lead to infertility. By prescribing oral antibiotics like azithromycin (Zithromax) and doxycycline, the infection can be clear up within two to three weeks.
Session 7: Gender Inequality and HIV
In Sub-Saharan Africa particularly, young girls and women are getting affected by HIV. Inequalities between the genders make girls more vulnerable and prone to HIV and other related diseases. These inequalities arise due to cultural, social as well as economic issues. In many cases, biased social and cultural norms are interpreted into laws which act as blockades to HIV services for women, increasing their helplessness to HIV.
Session 8: Progress for HIV Vaccine
HIV reproduces and mutates so fast, that antibodies produced against the virus quickly get ineffective against newer viruses. This is why stimulating antibody production can’t clear the infection. HIV has various sub-types like type-B, type-C etc. found in different region. The vaccine to be develop must be effective against all sub-types of HIV. RV144 vaccine is now being tested. Imbokodo is testing a prime-boost vaccine. Jassen tested a vaccine on 2600 women aged 18 to 35 and the results are expected by 2022.
Session 9: HIV: Treatment for All
For the treatment of HIV infection, antiretroviral therapy (ART) is used. Also there is a regular take-up of HIV medicines called HIV treatment regimen being with a combination for the people those are on ART. ART is universal recommended therapy for everyone who has HIV. Although the HIV medicines and ART can’t cure HIV, these medicines help people with HIV to live long and healthy. People with HIV should talk to their health care provider about their life style that can possibly affect with those side-effects before starting HIV medicines.
Session 10: Preventing STD & STI
STD & STI can cause severe damage to the body, which can also result in death. These are caused by bacterial & viral infection. Especially teenagers and adult needs to take care the proper preventions and protection to avoid any disease related to this. Antiviral drugs are to be taken as a daily suppressive therapy with prescription. People with STDs or STIs should go for prevention and also go for yearly checkup and test.
Session 11: SDG & AIDS Care
The goal of Sustainable Development for 2030 reflects the complexity of the modern life as well as the side effect of all these. As we all know HIV cannot be ended without addressing the issue of health and vulnerability. People living with this epidemic are often live in fragile communities and are most affected by the inequality and discrimination. The SDG set the goal to end this and we all should be a part of that goal.
Session 12: Reproductive Health & Contraception
In choosing a method of contraception, dual protection from the simultaneous risk for HIV and other STDs also should be considered. Although hormonal contraceptives and IUDs are highly effective at preventing pregnancy, they do not protect against STDs, including HIV. Consistent and correct use of the male latex condom reduces the risk for HIV infection and other STDs, including chlamydial infection, gonococcal infection, and trichomoniasis.
Session 13: A World without HIV
With speedy implementation of effective prevention and treatment tools we have achieved a lot of reduction in cases related to HIV, STD as well as STI. However given the range of the epidemic we need to look for the effective and safe HIV vaccine. Also providing a realistic and cost-effective means of treatment for the whole population will be a great achievement. We all should work towards a world without HIV and diseases resulting out of it.
About HIV, STD & STI:
We take the pride to welcome you to the “3rd International Conference on HIV, STD & STI” to be conducted on April 22-23, 2020 at Singapore Town, Singapore. Theme of the conference is “Aiming for a HIV free society”. HIV 2020 conference gathers noted Eminent Scientists/Research Professors, Junior/Senior analysis fellows, Students, Doctors also researchers from World Health Societies & Associations and Medical Universities under one roof where networking and world partnering happens for the acceleration of future research.
Why to attend HIV 2020:
HIV 2020 Conference is composed of many intriguing educational programs along with multiple panels, workshops, affinity cluster lunches, paper displays, and scientific sessions by professionals. Everybody being a part of this conference gets certification for his/her participation and a platform to reconstruct client base. We arrange to offer all delegates and great professors with all potential basic amenities and for attendees a source of information concerning all the upcoming technologies lined up.
Importance and Scope:
Theme of the conference “Aiming for a HIV Free Society” conveys the essential notion that we tend to showcase to the planet. HIV 2020 prioritizes the high quality researches and technologies used for human health, welfare and convenience. Folks from each genre i.e. the extremely classified professionals, scientists, researchers and young innovators have an excellent deal during this as they will be having an opportunity for diversification and world communication. We tend to believe HIV 2020 can start up as a seminar study and a platform jam-packed with public awareness.
Business worth of HIV:
In June 1981, scientists reported the first clinical evidence of a disease known as acquired immunodeficiency syndrome, or AIDS. Its cause, the human immunodeficiency virus (HIV), was acknowledged in 1983. Since the start of the epidemic in 1981, around 75 million have become infected with HIV and around 32 million people have died of AIDS-related illnesses. In 2018, there were 37.9 million people living with HIV.
New HIV infections have fallen by 16% since 2010 (by 41% among children) and AIDS-related deaths have fallen by 55% since the peak in 2004. The United Nation family has been in the forefront of this improvement. Ending AIDS by 2030 is an integral part of the Sustainable Development Goals (SDGs), which were unanimously adopted by United Nations Member States in 2015.
HIV Treatment Access: in 2018, 23.3 million folks with HIV (62%) were accessing antiretroviral medical care (ART) globally, a rise of one.6 million since 2017 and up from eight million in 2010.
Mother-to-Child Transmission: In 2018, ninety two of pregnant ladies with HIV received ART to stop transmission HIV to their babies throughout physiological state and childbearing and to shield their own health. This is often compared to forty ninth in 2010.
AIDS-related Deaths: AIDS-related deaths are reduced by over fifty fifth since the height in 2004. In 2018, around 770,000 folk sided from AIDS-related diseases worldwide, compared to one.2 million in a pair of010 and one.7 million in 2004.
Regional Impact: the overwhelming majority of individuals with HIV are in low- and middle-income countries. In 2018, there have been twenty.6 million folks with HIV (57%) in Japanese and southern continent, 5.0 million (13%) in western and Central African Republic, 5.9 million (16%) in Asia and therefore the Pacific, and 2.2 million (6%) in Western and Central Europe and North America
Funding for HIV:
• To finish AIDS as a public health threat by 2030, UNAIDS estimates that US$26.2 billion are going to be needed for the world HIV response in two020 alone. This implies the planet should increase the number of resources out there for HIV by US$1.5 billion every year between 2016 and 2020, a scenario that's wanting more and more unlikely.
• In recent years, high-income countries have reduced funding for the HIV response in low- and middle-income countries, with a seven-membered decrease according between 2015 and 2016. Philanthropic donations, on the opposite hand, have up for the past 3 consecutive years.
Universities related to HIV/AIDS Worldwide:
Wayne State University
University of Maryland
University Of Miami
University of Georgia
University of Illinois
University of Minnesota
University of Charleston
West Virginia University
University of Cambridge
University of Oxford
University of Copenhagen
University College London
Swiss Federal Institute of Technology Zurich
Imperial College London
University of Zurich
University of Manchester
University of Munich
University of Edinburgh
Pierre and Marie Curie University
Catholic University of Leuven
University of Helsinki
University of Tokyo
National University of Singapore
Tel Aviv University
University of Hong Kong
Hebrew University of Jerusalem
Seoul National University
National Taiwan University
Sun Yat-sen University
American University of Kuwait
The Lebanese American University (LAU)
Weill Cornell Medical College in Qatar
Paris-Sorbonne University Abu Dhabi
Mohammed bin Rashid University of Medicine and Health Sciences
King Saud bin Abdulaziz University for Health Sciences
King Saud University
Gulf Medical University
HIV Related Association & Societies:
American Academy of HIV Medicine
American Sexual Health Association
Association of Nurses in AIDS Care
Association for Professionals in Infection Control and Epidemiology
International AIDS Society – USA
International AIDS Society
Infectious Diseases Society of America
British HIV Association
Australasian Society for HIV Medicine
HIV Medicine Association
International Association of Physicians in AIDS Care
National Medical Association
HIV Medicine Association
The European AIDS Clinical Society
Aids Hilfe Wien Austria
EATG (European AIDS Treatment Group) Belgium
Czech AIDS Help Society Czech Republic
AIDS Fondnet Denmark
Deutche AIDS-Hilfe / AIDS Action Europe Germany
Global Network of People Living with HIV Netherlands
ARAS - Romanian Association against AIDS Romania
Alliance Global Ukraine
European AIDS Treatment Group
HIV Pharmacy Association
National AIDS Programme
National Center for HIV/AIDS, Dermatology and STDs
Hong Kong AIDS Foundation
The Society for AIDS Care
HIV Medicine Association of India
AIDS Clinical Center
Korean HIV/AIDS Prevention and Support Center
Taiwan Tongzhi Hotline Association
Egyptian AIDS Society
Egyptian Network of NGOs fighting AIDS
AIDS Research Center of Iran
HATAM - HIV/AIDS Treatment and Research Center
Pozitif Yasam Dernegi (Positive Living Association)
Saudi Charity Association for AIDS Patients
National AIDS Programme
Israel AIDS task force
National HIV/AIDS program
Centres for Disease Control (CDC)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Child Health and Human Development (NICHD)
NIH Office of AIDS Research (OAR)
Elton john AIDS foundation
Mac AIDS fund
The global fund
The Road Ahead:
HIV market can see modest growth to $22.5 billion by 2025.
The human immunological disorder virus (HIV) market across the 9 major countries of the USA, France, Germany, Italy, Spain, the UK, Japan, Brazil, and China, is about to grow from $16.3 billion in 2015 to $22.5 billion by 2025, representing a compound annual rate of simply over three-dimensional, in step with Global Data, a recognized leader in providing business info and analytics.
HIV 2020 through this learning experience dreams for a society where HIV infections are rare and when they do follow, all person, irrespective of age, gender, race/ethnicity, sexual orientation, gender identity or socio-economic circumstance, will have unrestricted access to high quality, life-extending care, free from disgrace and discrimination.
Young Scientist Awards at HIV 2020 for the best researches in HIV/AIDS, STD & STI
Meetings International is announcing Young Scientist Awards through 3rd International Conference on HIV/AIDS, STD & STI (HIV 2020) which is scheduled at Singapore City, Singapore during April 22-23, 2020. This HIV/AIDS Conference focuses on “Aiming for a HIV Free Society”.
HIV 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of environmental science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
HIV 2020 focuses mainly on Evolution of HIV, HIV & Chronic Disease, HIV and Pregnancy, Living with HIV, AIDS Research and Therapy, STD, STIs and Infertility, Gender Inequality and HIV, Progress for HIV Vaccine, HIV: Treatment for all, Preventing STD & STI, SDG & AIDS Care, Reproductive Health & Contraception, A World without HIV. HIV conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.
Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
- Acknowledgement as YRF Awardee
- Promotion on the conference website, Young Researcher Awards and certificates
- Link on the conference website
- Recognition on Meetings Int. Award Page
- Chances to coordinate with partners around the world
- Research work can be published in the relevant journal without any publication fee
- All presented abstracts will automatically be considered for the Award.
- All the presentation will be evaluated in the conference venue
- All the awards will be selected by the judges of the award category
- The winners of the Young Scientist Award will receive award certificate.
- The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.
- All submissions must be in English.
- The topic must fit into scientific sessions of the conference
- Each individual participant is allowed to submit maximum 2 papers
- Abstract must be submitted online as per the given abstract template
- Abstracts must be written in Times New Roman and font size will be 12
- Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.
Official announcement of the recipients will occur after the completion of Recycling Conference.